Circulating tumor tissue modified viral (TTMV)-HPV DNA in Recurrent, metastatic HPV-driven oropharyngeal cancer.

Autor: Hanna GJ; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address: glenn_hanna@dfci.harvard.edu., Jabalee J; Naveris, Inc., Natick, MA, USA., Lukens JN; Head & Neck Service, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Sun L; Head & Neck Service, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Rettig EM; Center for Head & Neck Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ferrandino R 2nd; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Posner MR; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Misiukiewicz KJ; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Routman DM; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., Van Abel KM; Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA., Del Vecchio Fitz C; Naveris, Inc., Natick, MA, USA., Roof SA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Publikováno v: Oral oncology [Oral Oncol] 2024 Nov; Vol. 158, pp. 107002. Date of Electronic Publication: 2024 Aug 18.